Profilo
Douglas Maffei worked as a Senior Director of Investor Relations at Gilead Sciences, Inc. He later became a Vice President of Investor Relations at Seagen Inc.
Precedenti posizioni note di Douglas Maffei
| Società | Posizione | Fine |
|---|---|---|
| SEAGEN INC. | Contatto Relazioni con gli Investitori | 01/12/2023 |
| GILEAD SCIENCES, INC. | Contatto Relazioni con gli Investitori | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
- Borsa valori
- Insiders
- Douglas Maffei
